Kilter Group’s BioNTech BNTX Stock Holding History

Kilter Group’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$94	Buy	+1	New	+$94	﹤0.01%	1527

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

Kilter Group's BNTX Position: Q2 2026 in Review

Kilter Group opened a new position in BioNTech (BNTX) in Q2 2026: 1 share worth $94. The stake represents ﹤0.01% of the portfolio and ranks #1527 among its holdings.

281 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

Kilter Group held 1 share of BioNTech worth $94 as of Q2 2026.
BioNTech was a new Kilter Group position in Q2 2026.
BioNTech made up ﹤0.01% of Kilter Group's portfolio in Q2 2026, its #1527 holding.
281 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Kilter Group's 13F filing for Q2 2026, filed 11 Aug 2026.